ZYTO Corp. Announces New Member to Scientific Advisory Board

LINDON, UT--(Marketwire - June 19, 2012) -

ZYTO Corp (OTCBB: ZYTC) (www.ZYTO.com).

ZYTO Corp, a Utah-based biotech company specializing in biocommunication applications, today announced that Dr. Bruce H. Shelton, MD, MD(H), DiHOM, FBIH, has joined its Scientific Advisory Board.

Vaughn R Cook, OMD, ZYTO’s CEO, said, “Dr. Shelton’s expertise in integrative medicine is acknowledged in the biotechnology industry and we are very pleased to have him as a contributing member of our advisory board. His background and experience is very valuable to ZYTO as we continue to enhance our products and develop more research programs.”

“Dr. Shelton’s unique experience in the allopathic and homeopathic fields will be an asset to ZYTO as we move our company forward,” said Kami J. Howard, ZYTO’s President.

As a licensed Medical Doctor, Dr. Shelton has lectured and published extensively in the fields of alternative medicine and homeopathy and is recognized as one of the industry’s foremost authorities.

The members of ZYTO’s Scientific Advisory Board include: Lee Cowden, MD; Dennis Cozzocrea, DC; Jane Oelke, ND, PhD; and Bruce H. Shelton, MD, MD(H), DiHOM, FBIH.

For a complete biography on each member, please visit http://www.ZYTO.com/advisoryboard.html.

The Scientific Advisory Board meets periodically throughout the year. The next meeting will be held on July 21, 2012.

About ZYTO Corp

ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer technology to facilitate decision making about healthcare and wellness options.

For more information visit www.ZYTO.com or contact their Headquarters at 801-224-7199.

Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO’s marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO’s stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company’s products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company’s periodic reports. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.

Digg this Bookmark with del.icio.us Add to Newsvine

Technorati: ZYTO Hand Cradle Biotech Bio communication Biofeedback Health Scan ZITO Biotechnology Elite